The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Efficient blood sugar control plays a major role in preventing diabetes, a disease affecting millions around the world. Detecting problems early, though, has always been tough.

DexCom, Inc. (NASDAQ:DXCM – Get Free Report)’s share price gapped down prior to trading on Tuesday after an insider sold ...

In Q2 2025 Finland’s medicines agency, FIMEA, granted GlucoModicum authorization to initiate a new clinical investigation under Article 62 of the EU MDR (2017/745), enabling GlucoModicum to generate ...

CGM use vs self-monitoring was not associated with improved obstetric or neonatal outcomes among women with gestational diabetes.

ALR Technologies SG Ltd. ('ALRT' or the 'Company') (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical Technology Shen ...

Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

Stocks of companies that sell these devices have seen a surge following his commentary. Abbott Laboratories (ABT) and DexCom ...

Allspring Global Investments Holdings LLC grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 558.3% during the ...